Watchlist Price Alert

Titan Pharmaceuticals Inc... (TTNP)

NASDAQ: TTNP · Real-Time Price · USD

4.26

0.06 (1.43%)

At close: Jul 01, 2025, 2:00 PM

4.18

-1.88%

After-hours: Jul 01, 2025, 06:59 PM EDT

Titan Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	2.83M	6.76M	2.94M	6.04M	5.41M	5.22M	9.29M	7.52M	14.01M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	48K	48K	-759K	-1.21M	n/a	n/a	n/a
Receivables	62K	1.05M	36K	112K	884K	438K	1.84M	65K	3.59M
Inventory	n/a	n/a	106K	293K	328K	998K	1.26M	n/a	n/a
Other Current Assets	30K	212K	524K	307K	181K	1.55M	361K	361K	237K
Total Current Assets	2.92M	8.02M	3.6M	7.23M	7.33M	8.31M	13.3M	8.31M	17.83M
Property-Plant & Equipment	n/a	68K	407K	717K	759K	1.21M	794K	595K	837K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	68K	455K	765K	759K	1.21M	794K	595K	837K
Total Assets	2.92M	8.09M	4.06M	7.99M	8.09M	9.52M	14.1M	8.9M	18.67M
Account Payables	202K	348K	695K	795K	1.25M	815K	1.53M	821K	3.02M
Deferred Revenue	n/a	12K	196K	295K	533K	n/a	313K	n/a	n/a
Short-Term Debt	n/a	500K	122K	112K	477K	272K	527K	3M	n/a
Other Current Liabilities	n/a	n/a	129K	1.03M	1.81M	1.81M	n/a	n/a	n/a
Total Current Liabilities	483K	1.44M	2.63M	2.67M	4.22M	3.6M	3.45M	4.46M	4.86M
Long-Term Debt	n/a	n/a	n/a	n/a	332K	4.02M	3.79M	3.58M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	320K	25K	n/a	619K
Total Long-Term Liabilities	n/a	n/a	65K	187K	332K	4.49M	3.81M	3.58M	619K
Total Liabilities	483K	1.44M	2.69M	2.86M	4.55M	8.09M	7.26M	8.05M	5.48M
Total Debt	n/a	565K	187K	299K	809K	4.44M	4.31M	6.58M	n/a
Common Stock	1K	1K	1K	10K	7K	57K	13K	297.86M	297.86M
Retained Earnings	-396.54M	-391.83M	-386.26M	-376.06M	-367.28M	-349.04M	-332.58M	-323.27M	-308.96M
Comprehensive Income	n/a	n/a	0.00	n/a	n/a	-0.00	-4.44M	-4.06M	-3.64M
Shareholders Equity	2.44M	6.64M	1.36M	5.14M	3.53M	1.43M	6.83M	857K	13.19M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a